Amanote Research
Register
Sign In
Mitochondrial Apoptotic Priming Regulates Therapeutic Responses in AML
Cancer Discovery
- United States
doi 10.1158/2159-8290.cd-rw2012-181
Full Text
Open PDF
Abstract
Available in
full text
Categories
Oncology
Date
October 18, 2012
Authors
Unknown
Publisher
American Association for Cancer Research (AACR)
Related search
Intersectin-1s Regulates the Mitochondrial Apoptotic Pathway in Endothelial Cells
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
miR-133 Regulates Evi1 Expression in AML Cells as a Potential Therapeutic Target
Scientific Reports
Multidisciplinary
The Mitochondrial Transacylase, Tafazzin, Regulates AML Stemness by Modulating Intracellular Levels of Phospholipids
Cell Stem Cell
Molecular Medicine
Genetics
Cell Biology
Mitochondrial Priming by CD28
Cell
Biochemistry
Genetics
Molecular Biology
Mitochondrial Apoptosis Is Dispensable for NLRP3 Inflammasome Activation but Non-Apoptotic Caspase-8 Is Required for Inflammasome Priming
EMBO Reports
Biochemistry
Genetics
Molecular Biology
Therapeutic Targeting of Isocitrate Dehydrogenase Mutant AML
Expert Opinion on Investigational Drugs
Medicine
Pharmacology
Apoptotic Signaling Pathways in Glioblastoma and Therapeutic Implications
BioMed Research International
Immunology
Molecular Biology
Biochemistry
Microbiology
Medicine
Genetics
Prime Retrieval of Motor Responses in Negative Priming.
Journal of Experimental Psychology: Human Perception and Performance
Arts
Cognitive Psychology
Humanities
Behavioral Neuroscience
Medicine
Experimental
Small Cell Lung Cancer Therapeutic Responses Through Fractal Measurements: From Radiology to Mitochondrial Biology
Journal of Clinical Medicine